Tibet Weixinkang Medicine Co Ltd Asset Resilience Ratio

Latest as of June 2026: 40.01%

Tibet Weixinkang Medicine Co Ltd asset resilience ratio. Tibet Weixinkang Medicine Co Ltd (603676) has an Asset Resilience Ratio of 40.01% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tibet Weixinkang Medicine Co Ltd (603676) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥786.15 Million

≈ $115.04 Million USD Cash + Short-term Investments

Total Assets

CN¥1.96 Billion

≈ $287.49 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Tibet Weixinkang Medicine Co Ltd (2016–2025)

Asset resilience ratio of Tibet Weixinkang Medicine Co Ltd from 2016 to 2025. This chart shows how Tibet Weixinkang Medicine Co Ltd's Asset Resilience Ratio has changed over time. Read Tibet Weixinkang Medicine Co Ltd (603676) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tibet Weixinkang Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Tibet Weixinkang Medicine Co Ltd (603676) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥786.15 Million	40.01%
Total Liquid Assets	CN¥786.15 Million	40.01%

Asset Resilience Insights

Very High Liquidity: Tibet Weixinkang Medicine Co Ltd maintains exceptional liquid asset reserves at 40.01% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Tibet Weixinkang Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tibet Weixinkang Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Tibet Weixinkang Medicine Co Ltd Asset Resilience Ratio by Year (2016–2025)

Tibet Weixinkang Medicine Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Tibet Weixinkang Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	41.25%	CN¥770.00 Million ≈ $112.68 Million	CN¥1.87 Billion ≈ $273.18 Million	-2.07pp
2024-12-31	43.32%	CN¥803.00 Million ≈ $117.50 Million	CN¥1.85 Billion ≈ $271.25 Million	+8.13pp
2023-12-31	35.19%	CN¥625.32 Million ≈ $91.50 Million	CN¥1.78 Billion ≈ $260.02 Million	+17.95pp
2022-12-31	17.24%	CN¥287.00 Million ≈ $42.00 Million	CN¥1.66 Billion ≈ $243.60 Million	-14.04pp
2021-12-31	31.28%	CN¥467.77 Million ≈ $68.45 Million	CN¥1.50 Billion ≈ $218.85 Million	+5.10pp
2020-12-31	26.18%	CN¥356.00 Million ≈ $52.09 Million	CN¥1.36 Billion ≈ $199.02 Million	-2.18pp
2019-12-31	28.35%	CN¥369.90 Million ≈ $54.13 Million	CN¥1.30 Billion ≈ $190.91 Million	-9.68pp
2017-12-31	38.04%	CN¥386.71 Million ≈ $56.59 Million	CN¥1.02 Billion ≈ $148.76 Million	+23.83pp
2016-12-31	14.21%	CN¥78.50 Million ≈ $11.49 Million	CN¥552.36 Million ≈ $80.83 Million	--

pp = percentage points

About Tibet Weixinkang Medicine Co Ltd

SHG:603676 China Drug Manufacturers - Specialty & Generic

Market Cap

$524.71 Million

CN¥3.59 Billion CNY

Market Cap Rank

#11627 Global

#3297 in China

Share Price

CN¥8.24

Change (1 day)

-1.90%

52-Week Range

CN¥8.04 - CN¥11.73

All Time High

CN¥24.05